{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:21:42Z","timestamp":1790216502327,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10585-021-10131-w","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T02:03:33Z","timestamp":1636337013000},"page":"527-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-6284","authenticated-orcid":false,"given":"Ciro","family":"Franzese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Marvaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Francolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Borghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Eolo","family":"Trodella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Sepulcri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Matrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Timon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ognibene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Vinciguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bortolus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Maria","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Livi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Arcangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"10131_CR1","unstructured":"AIOM-Airtum I numeri del cancro in Italia 2018 n.d."},{"key":"10131_CR2","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","volume":"37","author":"J Srigley","year":"2013","unstructured":"Srigley J, Delahunt B, Eble J, Egevad L, Epstein J, Grignon D et al (2013) The international society of urological pathology (ISUP) vancouver classification. Am J Surg Pathol 37:1469\u20131489","journal-title":"Am J Surg Pathol"},{"key":"10131_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ucl.2008.07.005","volume":"35","author":"GJ DeCastro","year":"2008","unstructured":"DeCastro GJ, McKiernan JM (2008) Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin North Am 35:581\u2013592. https:\/\/doi.org\/10.1016\/j.ucl.2008.07.005","journal-title":"Urol Clin North Am"},{"key":"10131_CR4","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1200\/JCO.2005.04.8280","volume":"24","author":"SE Eggener","year":"2006","unstructured":"Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P (2006) Renal cell carcinoma recurrence after nephrectomy for localized disease: Predicting survival from time of recurrence. J Clin Oncol 24:3101\u20133106. https:\/\/doi.org\/10.1200\/JCO.2005.04.8280","journal-title":"J Clin Oncol"},{"key":"10131_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.juro.2018.08.049","volume":"201","author":"C Franzese","year":"2019","unstructured":"Franzese C, Franceschini D, Di Brina L, D\u2019Agostino GR, Navarria P, Comito T et al (2019) Role of stereotactic body radiation therapy for the management of oligometastatic renal cell carcinoma. J Urol 201:70\u201376. https:\/\/doi.org\/10.1016\/j.juro.2018.08.049","journal-title":"J Urol"},{"key":"10131_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.radonc.2005.03.022","volume":"77","author":"PJ Wersall","year":"2005","unstructured":"Wersall PJ, Blomgren H, Lax I, Kalkner KM, Linder C, Lundell G et al (2005) Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 77:88\u201395. https:\/\/doi.org\/10.1016\/j.radonc.2005.03.022","journal-title":"Radiother Oncol"},{"key":"10131_CR7","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.ijrobp.2011.02.040","volume":"82","author":"MJ Zelefsky","year":"2012","unstructured":"Zelefsky MJ, Greco C, Motzer R, Magsanoc JM, Pei X, Lovelock M et al (2012) Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 82:1744\u20131748. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.02.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10131_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3171\/2012.8.SPINE12303","volume":"17","author":"EH Balagamwala","year":"2012","unstructured":"Balagamwala EH, Angelov L, Koyfman SA, Suh JH, Reddy CA, Djemil T et al (2012) Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma: clinical article. J Neurosurg Spine 17:556\u2013564. https:\/\/doi.org\/10.3171\/2012.8.SPINE12303","journal-title":"J Neurosurg Spine"},{"key":"10131_CR9","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.21037\/jtd.2017.10.108","volume":"9","author":"J Hoerner-Rieber","year":"2017","unstructured":"Hoerner-Rieber J, Duma M, Blanck O, Hildebrandt G, Wittig A, Lohaus F et al (2017) Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-A multicenter analysis of the German working group \u201cStereotactic Radiotherapy.\u201d J Thorac Dis 9:4512\u20134522. https:\/\/doi.org\/10.21037\/jtd.2017.10.108","journal-title":"J Thorac Dis"},{"key":"10131_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2019.100161","author":"S Buti","year":"2020","unstructured":"Buti S, Bersanelli M, Viansone A, Leonetti A, Masini C, Ratta R et al (2020) Treatment outcome of metastatic lesions from renal cell carcinoma undergoing extra-cranial stereotactic body radioTHERapy: the together retrospective study. Cancer Treat Res Commun. https:\/\/doi.org\/10.1016\/j.ctarc.2019.100161","journal-title":"Cancer Treat Res Commun"},{"key":"10131_CR11","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393:2051\u20132058. https:\/\/doi.org\/10.1016\/S0140-6736(18)32487-5","journal-title":"Lancet"},{"key":"10131_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.critrevonc.2017.07.004","volume":"117","author":"F Alongi","year":"2017","unstructured":"Alongi F, Arcangeli S, Triggiani L, Mazzola R, di Monale B, Bastia M, Fersino S et al (2017) Stereotactic ablative radiation therapy in renal cell carcinoma: from oligometastatic to localized disease on the behalf of Italian Association of Radiation Oncology [AIRO]. Crit Rev Oncol 117:48\u201356. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.07.004","journal-title":"Crit Rev Oncol"},{"key":"10131_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.clgc.2016.09.004","volume":"15","author":"N Dengina","year":"2017","unstructured":"Dengina N, Tsimafeyeu I, Mitin T (2017) Current role of radiotherapy for renal-cell carcinoma: review. Clin Genitourin Cancer 15:183\u2013187. https:\/\/doi.org\/10.1016\/j.clgc.2016.09.004","journal-title":"Clin Genitourin Cancer"},{"key":"10131_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijrobp.2019.07.023","volume":"105","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman I et al (2019) Stereotactic ablative radiation therapy (SAbR) used to defer systemic therapy in oligometastatic renal cell cancer. Int J Radiat Oncol Biol Phys 105:367\u2013375. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.07.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10131_CR15","doi-asserted-by":"crossref","unstructured":"Meyer E, Stefan D, Pasquier D, Bernadou G, Calais G, Carrie C, et al. (2016) Stereotactic radiotherapy (SRT) for oligometastatic (OM) relapse and metastatic oligoprogression (OP) in renal cell carcinoma (RCC) patients (pts): a study of the GETUG group. J Clin Oncol 34","DOI":"10.1200\/JCO.2016.34.15_suppl.e16105"},{"key":"10131_CR16","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s00345-019-02717-7","volume":"37","author":"L Triggiani","year":"2019","unstructured":"Triggiani L, Mazzola R, Magrini SMSM, Ingrosso G, Borghetti P, Trippa F et al (2019) Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. World J Urol 37:2631\u20132637. https:\/\/doi.org\/10.1007\/s00345-019-02717-7","journal-title":"World J Urol"},{"key":"10131_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.euo.2019.05.007","volume":"2","author":"NG Zaorsky","year":"2019","unstructured":"Zaorsky NG, Lehrer EJ, Kothari G, Louie AV, Siva S (2019) Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies. Eur Urol Oncol 2:515\u2013523. https:\/\/doi.org\/10.1016\/j.euo.2019.05.007","journal-title":"Eur Urol Oncol"},{"key":"10131_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.radonc.2018.04.028","volume":"127","author":"M Stenman","year":"2018","unstructured":"Stenman M, Sinclair G, Paavola P, Wers\u00e4ll P, Harmenberg U, Lindskog M (2018) Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005\u20132014. Radiother Oncol 127:501\u2013506. https:\/\/doi.org\/10.1016\/j.radonc.2018.04.028","journal-title":"Radiother Oncol"},{"key":"10131_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1748-717X-7-102","volume":"7","author":"J-E Bibault","year":"2012","unstructured":"Bibault J-E, Prevost B, Dansin E, Mirabel X, Lacornerie T, Lartigau E (2012) Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer. Radiat Oncol 7:102. https:\/\/doi.org\/10.1186\/1748-717X-7-102","journal-title":"Radiat Oncol"},{"key":"10131_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/153303461000900502","volume":"9","author":"W Kilby","year":"2010","unstructured":"Kilby W, Dooley JR, Kuduvalli G, Sayeh S, Maurer CR (2010) The CyberKnife\u00ae robotic radiosurgery system in 2010. Technol Cancer Res Treat 9:433\u2013452. https:\/\/doi.org\/10.1177\/153303461000900502","journal-title":"Technol Cancer Res Treat"},{"key":"10131_CR21","first-page":"4617","volume":"40","author":"G Marvaso","year":"2020","unstructured":"Marvaso G, Corrao G, Oneta O, Mazzola GC, Gugliandolo SG, Pepa M, Cecconi A, Gandini S, Piperno G, Rocca MC, Verri E, Aurilio G, Corso F, Cullura D, Rondi E, Vigorito S, Nole F, Orecchia R, Jereczek-Fossa BA (2020) SBRT for oligometastatic renal cell carcinoma. Anticancer Res 40:4617\u20134618","journal-title":"Anticancer Res"},{"key":"10131_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000535","author":"N Dengina","year":"2014","unstructured":"Dengina N, Mitin T, Gamayunov S, Safina S, Kreinina Y, Tsimafeyeu I (2014) Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study. ESMO Open. https:\/\/doi.org\/10.1136\/esmoopen-2019-000535","journal-title":"ESMO Open"},{"key":"10131_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijrobp.2017.01.032","volume":"98","author":"CJ Wang","year":"2017","unstructured":"Wang CJ, Christie A, Lin MH, Jung M, Weix D, Huelsmann L et al (2017) Safety and efficacy of stereotactic ablative radiation therapy for renal cell carcinoma extracranial metastases. Int J Radiat Oncol Biol Phys 98:91\u2013100. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.01.032","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10131_CR24","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","volume":"27","author":"DYC Heng","year":"2009","unstructured":"Heng DYC, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C et al (2009) Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: Results from a large, multicenter study. J Clin Oncol 27:5794\u20135799. https:\/\/doi.org\/10.1200\/JCO.2008.21.4809","journal-title":"J Clin Oncol"},{"key":"10131_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejca.2018.10.023","volume":"107","author":"F Ruatta","year":"2019","unstructured":"Ruatta F, Derosa L, Escudier B, Colomba E, Guida A, Baciarello G et al (2019) Prognosis of renal cell carcinoma with bone metastases: experience from a large cancer centre. Eur J Cancer 107:79\u201385. https:\/\/doi.org\/10.1016\/j.ejca.2018.10.023","journal-title":"Eur J Cancer"},{"key":"10131_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2020.06.003","author":"F Massari","year":"2020","unstructured":"Massari F, Di Nunno V, Guida A, Costa Silva CA, Derosa L, Mollica V et al (2020) Addition of primary metastatic site on bone, brain, and liver to IMDC criteria in patients with metastatic renal cell carcinoma: a validation study. Clin Genitourin Cancer. https:\/\/doi.org\/10.1016\/j.clgc.2020.06.003","journal-title":"Clin Genitourin Cancer"},{"key":"10131_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.radonc.2020.06.029","volume":"150","author":"C Franzese","year":"2020","unstructured":"Franzese C, Badalamenti M, Comito T, Franceschini D, Clerici E, Navarria P et al (2020) Assessing the role of stereotactic body radiation therapy in a large cohort of patients with lymph node oligometastases: does it affect systemic treatment\u2019s intensification? Radiother Oncol 150:184\u2013190. https:\/\/doi.org\/10.1016\/j.radonc.2020.06.029","journal-title":"Radiother Oncol"},{"key":"10131_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00987","author":"F Weykamp","year":"2020","unstructured":"Weykamp F, K\u00f6nig L, Seidensaal K, Forster T, Hoegen P, Akbaba S et al (2020) Extracranial stereotactic body radiotherapy in oligometastatic or oligoprogressive breast cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.00987","journal-title":"Front Oncol"},{"key":"10131_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.07.026","author":"P Cheung","year":"2021","unstructured":"Cheung P, Patel S, North SA, Sahgal A, Chu W, Soliman H et al (2021) Stereotactic radiotherapy for oligoprogression in metastatic renal cell cancer patients receiving tyrosine kinase inhibitor therapy: a phase 2 prospective multicenter study. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2021.07.026","journal-title":"Eur Urol"},{"key":"10131_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15284","author":"SGC Kroeze","year":"2020","unstructured":"Kroeze SGC, Fritz C, Schaule J, Siva S, Kahl KH, Sundahl N et al (2020) Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma. BJU Int. https:\/\/doi.org\/10.1111\/bju.15284","journal-title":"BJU Int"},{"key":"10131_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1042198","volume":"4","author":"K De Wolf","year":"2015","unstructured":"De Wolf K, Vermaelen K, De Meerleer G, Lambrecht BN, Ost P (2015) The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy. Oncoimmunology 4:e1042198. https:\/\/doi.org\/10.1080\/2162402X.2015.1042198","journal-title":"Oncoimmunology"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10131-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-021-10131-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10131-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T22:04:30Z","timestamp":1637100270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-021-10131-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10131"],"URL":"https:\/\/doi.org\/10.1007\/s10585-021-10131-w","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}